Parallel Advisors’s Ginkgo Bioworks DNA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.33K | Buy |
474
+248
| +110% | +$2.79K | ﹤0.01% | 2694 |
|
|
2025
Q1 | $1.29K | Buy |
226
+56
| +33% | +$319 | ﹤0.01% | 3056 |
|
|
2024
Q4 | $1.67K | Hold |
170
| – | – | ﹤0.01% | 2994 |
|
|
2024
Q3 | $1.39K | Sell |
170
-23
| -12% | -$188 | ﹤0.01% | 2953 |
|
|
2024
Q2 | $2.58K | Sell |
193
-96
| -33% | -$1.28K | ﹤0.01% | 2715 |
|
|
2024
Q1 | $13.4K | Buy |
289
+10
| +4% | +$464 | ﹤0.01% | 2174 |
|
|
2023
Q4 | $18.8K | Sell |
279
-33
| -11% | -$2.23K | ﹤0.01% | 1987 |
|
|
2023
Q3 | $22.6K | Buy |
312
+3
| +1% | +$217 | ﹤0.01% | 1778 |
|
|
2023
Q2 | $23K | Buy |
309
+110
| +55% | +$8.19K | ﹤0.01% | 1783 |
|
|
2023
Q1 | $10.6K | Sell |
199
-62
| -24% | -$3.3K | ﹤0.01% | 2103 |
|
|
2022
Q4 | $17.6K | Buy |
261
+59
| +29% | +$3.99K | ﹤0.01% | 1766 |
|
|
2022
Q3 | $25K | Buy |
202
+32
| +19% | +$3.96K | ﹤0.01% | 1566 |
|
|
2022
Q2 | $16K | Buy |
+170
| New | +$16K | ﹤0.01% | 1745 |
|
|
2021
Q4 | – | Sell |
-63
| Closed | -$29K | – | 3128 |
|
|
2021
Q3 | $29K | Buy |
+63
| New | +$29K | ﹤0.01% | 1527 |
|